Clinical Trials Directory

Trials / Unknown

UnknownNCT05273905

Augmented Velocity Index of Intra-abdominal, Carotid and Retinal Arteries

Augmented Velocity Index of Intra-abdominal, Carotid and Retinal Arteries: In Relation to Arterial Stiffness and Cardiovascular Risk Factors.

Status
Unknown
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Background: Augmented Velocity Index (Avi) is a new Doppler index which can potentially be used to assess arterial stiffness. The Avi of common carotid artery is found to be associated with arterial stiffness and have initial correlation with cardiovascular risk factors. Avi can be used in any vessels (superficial or deep vessels) where arterial Doppler waveforms can be obtained. Aims: The aims of this study are to investigate the associations of Avi of hepatic artery, renal artery, central retinal artery and internal carotid artery with arterial stiffness and cardiovascular risk factors in a group of apparently normal subjects. Methods: Recruit 350 subjects with no known medical illness or drug treatment for ultrasound examinations and blood tests. In ultrasound examination, the Avi of carotid arteries, hepatic arteries, renal arteries and retinal arteries are recorded. The carotid-femoral pulse wave velocity is also calculated for the assessment of central aortic stiffness. Other important correlates of arterial stiffness including carotid intima-media thickness, fatty liver status, liver stiffness and abdominal fat thickness are assessed in the ultrasound examination. The clinical and laboratory examinations include anthropometric indexes, plasma glucose level, lipid profile, renal function tests, liver function test, urinary albumin creatinine ratio, blood pressure measurement.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasound derived AviAssess the Avi of carotid arteries, hepatic arteries, renal arteries and central retinal arteries.

Timeline

Start date
2022-05-01
Primary completion
2024-08-01
Completion
2025-03-01
First posted
2022-03-10
Last updated
2022-03-24

Source: ClinicalTrials.gov record NCT05273905. Inclusion in this directory is not an endorsement.